Press release
Proteros and Institut Pasteur Korea establish discovery services collaboration in the field of infectious diseases
Martinsried, Germany, May 24, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K. Under this collaboration Proteros will apply its know-how, experience of structural analysis and its proprietary X-ray crystallography platform to support IP-K’s mission to develop therapeutics for infectious diseases.Cony D’Cruz, Chief Business Officer of Proteros, stated, “Institut Pasteur Korea is a world class translational research institute, renowned as a centre of excellence in biomedical research and technology development with a clear focus on infectious and neglected disease. We welcome the opportunity for Proteros to contribute to these efforts.”
Dr. Michel Liuzzi, Director, Early Discovery Program at IP-K, added "We are very pleased with the expertise and know-how of Proteros in providing timely X-ray crystallography support to our in-house drug discovery projects and we look forward to continue collaborating with Proteros in the future."
About Proteros:
Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables ‘knowledge driven lead engineering’ to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia.
About Institut Pasteur Korea:
Institut Pasteur Korea (IP-K) is an independent non-profit institute founded in April, 2004 with a strategic focus on enabling technologies and therapeutic development in disease models pertaining to public health. IP-K has developed a novel research platform that combines chemical genomics with high content visual screening by bringing together the latest advances in biology, technology, and chemistry. The application of the platform technology in the fields of infectious disease and chronic illness allows basic science to be extended to drug discovery. In turn the application of functional genomics - using global siRNA - allows further elucidation of the basic molecular and genetic underpinnings of disease. Visit http://www.ip-korea.org.
Contact:
Proteros biostructures GmbH
Kurt Herrenknecht, Ph.D.
Am Klopferspitz 19
82152 Martinsried
Germany
Phone: +49 (0) 89 7007 61 0
E-Mail: business@proteros.com
Internet: www.proteros.com
Institut Pasteur Korea
Jean Kim
Sampyeong-dong 696
Bundang-gu, Seongnam-si, Gyeonggi-do
Korea
Phone: +82 (0) 31 8018 8041
E-Mail: publicrelations@ip-korea.org
Internet: www.ip-korea.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Proteros and Institut Pasteur Korea establish discovery services collaboration in the field of infectious diseases here
News-ID: 176395 • Views: …
More Releases from Proteros biostructures GmbH
PROTEROS ANNOUNCES SUCCESSFUL CLOSE OF FINANCING ROUND
Largest-ever Financing allows for Expansion of Drug Discovery Capabilities
MARTINSRIED, GERMANY (August 6th, 2012) – Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed a financing round of five million Euros to fund the continued expansion and growth of the company.
The financing round was led by BayBG, a key equity investor for Proteros. The financing round is the third and largest investment into the firm since the inception…
Proteros and Eisai Co., Ltd enter into Integrated Lead Discovery Collaboration
Martinsried (Germany), April 16, 2012. Proteros biostructures GmbH today announced that the company has entered into a research collaboration with Eisai Co., Ltd (Japan) to identify small molecule inhibitors against a target selected by Eisai in the field of immunology.
Under the agreement Proteros will deliver a novel lead compound applying its integrated lead discovery platform that includes X-Ray structural biology, biophysical screening and profiling, novel fragment libraries and medicinal chemistry…
Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific O …
Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas.
At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for…
Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global …
Martinsried Jan 09, 2012. Janssen Research & Development, a division of Janssen Pharmaceutica NV (“Janssen”) and Proteros biostructures GmbH (“Proteros”) today announced they have entered into a long-term global service agreement granting Janssen privileged access to Proteros portfolio of discovery technologies and services.
Under the agreement Janssen will have broad access to Proteros’ drug discovery technologies, including structural biology, biophysical screening and profiling service, novel fragment libraries, medicinal chemistry expertise and…
More Releases for Korea
Talk Talk Korea 2025 Invites Global Submissions for a Chance to Visit Korea
Join Talk Talk Korea 2025: Submit Your Creative Take on Korea by August 5!
The Ministry of Culture, Sports and Tourism (Minister Yu In Chon, MCST) will hold an international content contest, "Talk Talk Korea 2025" from June 2 (Monday) to August 5 (Tuesday), and is inviting people around the world to participate.
Image: https://www.globalnewslines.com/uploads/2025/06/3475f2aed29a9215f452a1af29735fff.jpg
Marking its 12th anniversary this year, the contest has grown into a major event for Hallyu content, and…
Korean Red Ginseng Market to Witness Huge Growth by 2031 -Korea Ginseng Corp., D …
DataM Intelligence has published a new research report on "Korean Red Ginseng Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF…
Stem Cell Therapy Market | Smith+Nephew (UK), MEDIPOST Co., Ltd. (South Korea), …
Stem Cell Therapy Market in terms of revenue was estimated to be worth $286 million in 2023 and is poised to reach $615 million by 2028, growing at a CAGR of 16.5% from 2023 to 2028 according to a new report by MarketsandMarkets. The global stem cell therapy market is expected to grow at a CAGR of 16.8% during the forecast period. The major factors driving the growth of the…
2021 South Korea Power Market Report- Major Generating Companies: Korea Electric …
South Korea Power Market Report study provides detailed information to understand the imperative market parts that align with the business decision related to raw materials, demand, and production capacity. In addition, South Korea Power Market
analysis provides demands for the future, besides the available opportunities for the individuals. This helps manufacturers and clients understand the past trends and analyze the future trend.
Get FREE PDF Sample of the Report @…
Global Bamboo Salt Market Research Study, Future Prospects and Growth Drivers to …
Global Bamboo Salt Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2028, recently distributed by IndexMarketsResearch systematically arranges the foremost components of the market study. The report helps customers in anticipating investment in an developing market, extension of market share, or accomplishment of a new product with the help of global Bamboo Salt market research analysis. The worldwide Bamboo Salt market segmentation is controlled intimately upheld various parameters…
South Korea Agriculture Market | South Korea Agriculture Industry | Covid-19 Imp …
Agriculture in South Korea may be a sector of the economy of South Korea. The natural resources needed for agriculture in South Korea aren’t torrential. Two thirds of the country are mountains and hills. Productive land solely accounts for 22 percent of the country's land. The foremost vital crop in South Korea is rice, secretarial regarding 90 percent of the country's total grain production and over 40 percent of farm…
